Analyst Ratings with Price Target (PT)

[Ammeo 10]

will be updating majority of the analyst ratings on stock companies from different many analysts one daily basis, the idea is to sum up all the ratings in one place especially those given with a Price Target (PT).

[Ammeo 10]

1/23/2014

 

Stryker Boosts PT on Stryker ($SYK) to $75, Maintains 'Hold' Rating Into Q4 Report

Medivation ($MDVN) PT Raised at Goldman Sachs

Goldman Sachs Raises PTs on Las Vegas Sands ($LVS) and Wynn Resorts ($WYNN)

Apple ($AAPL) PT Raised to $700 at Avondale Partners

JPMorgan Upgrades Alcoa ($AA) to Overweight; Analyst Sees Tightening Aluminum Market

Cantor Boosts PT on Syneron Medical ($ELOS); Sees Tough Q4, But FY4 Should Fare Well

Google ($GOOG) PT Raised to $1450 at Pacific Crest

Roth Capital Boosts PT on Keryx Biopharma ($KERX) to $30

Herbalife ($HLF) PT Raised to $94 at Barclays

Virtusa ($VRTU) Target Priced Raised to $41 at Needham & Company

Chardan Capital Markets Starts Hemispherx ($HEB) at Buy, $3 PT

Nomura Securities Starts Hilton Worldwide ($HLT) at Buy, $26 PT

Needham & Company Upgrades Sarepta Therapeutic ($SRPT) to Buy, $36 PT

Goldman Sachs ($GS) Target Priced Lifted to $200 at FBR Capital Post Q4

Elizabeth Arden ($RDEN) PT Reduced to $25-$27 at Wells Fargo

Alnylam Pharma ($ALNY) Target Raised to $108 at Deutsche Bank

Illumina ($ILMN) Price Target Raised to $190 at JPMorgan

FBR Capital Lifts PT on Expedia ($EXPE) to $85